Catalyst Pharmaceuticals, Inc.
CPRX
$19.88
-$0.7419-3.60%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 73.76% | 87.06% | 276.03% | 265.65% | 110.13% |
| Total Receivables | 15.77% | 19.17% | 22.06% | 20.90% | 33.28% |
| Inventory | 3.53% | -0.88% | 24.91% | 121.55% | 67.56% |
| Prepaid Expenses | -11.96% | 4.18% | 66.01% | 31.34% | 170.92% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 20.68% | -70.50% | 193.45% | 147.09% | 465.93% |
| Total Current Assets | 59.93% | 69.48% | 184.33% | 180.70% | 96.88% |
|
|
|||||
| Total Current Assets | 59.93% | 69.48% | 184.33% | 180.70% | 96.88% |
| Net Property, Plant & Equipment | -10.14% | -9.36% | -3.21% | -2.13% | -6.40% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -21.31% | -20.24% | -19.26% | -0.65% | -0.13% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 27.11% | 25.98% | 25.83% | 29.51% | 69.82% |
| Total Assets | 37.59% | 40.55% | 81.11% | 86.83% | 59.13% |
|
|
|||||
| Total Accounts Payable | -22.32% | 9.12% | 12.15% | 151.48% | 60.96% |
| Total Accrued Expenses | 34.01% | 40.24% | 33.67% | 37.39% | 39.87% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.83% | 8.75% | 8.94% | 8.86% | 9.07% |
| Total Finance Division Other Current Liabilities | 21.71% | 47.45% | 141.77% | 132.99% | 110.83% |
| Total Other Current Liabilities | 21.71% | 47.45% | 141.77% | 132.99% | 110.83% |
| Total Current Liabilities | 22.41% | 40.32% | 58.66% | 82.33% | 75.83% |
|
|
|||||
| Total Current Liabilities | 22.41% | 40.32% | 58.66% | 82.33% | 75.83% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.01% | -13.26% | -12.61% | -11.97% | -11.40% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -87.10% | -90.07% | -89.44% | -22.10% | -81.17% |
| Total Liabilities | 18.61% | 34.39% | 50.52% | 71.77% | 42.42% |
|
|
|||||
| Common Stock & APIC | 9.14% | 8.52% | 65.95% | 64.71% | 64.02% |
| Retained Earnings | 112.58% | 136.53% | 135.14% | 165.22% | 58.15% |
| Treasury Stock & Other | -- | -- | 357.14% | -- | -- |
| Total Common Equity | 40.64% | 41.48% | 87.59% | 89.63% | 62.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 40.64% | 41.48% | 87.59% | 89.63% | 62.18% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 40.64% | 41.48% | 87.59% | 89.63% | 62.18% |
|
|
|||||